Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank78
Studio
Year-over-Year Change

Free cash flow yield

Latest
-30.33%
↓ 104% vs avg
Percentile
P78
Within normal range
Streak
4 yr
Consecutive growthCompressed
Average
745.52%
Historical baseline
PeriodValueYoY Change
2025-30.33%+49.2%
2024-59.70%+23.2%
2023-77.69%+37.9%
2022-125.05%+3.7%
2021-129.80%-171.7%
2020-47.77%+7.7%
2019-51.73%-12.0%
2018-46.18%-100.9%
20135200.86%+84.3%
20122822.59%-